These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30911077)

  • 1. HPV-negative tumors of the uterine cervix.
    Nicolás I; Marimon L; Barnadas E; Saco A; Rodríguez-Carunchio L; Fusté P; Martí C; Rodriguez-Trujillo A; Torne A; Del Pino M; Ordi J
    Mod Pathol; 2019 Jul; 32(8):1189-1196. PubMed ID: 30911077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of genotyping and p16 immunostaining in HPV-positive tumors of the uterine cervix.
    Nicolás I; Saco A; Barnadas E; Marimon L; Rakislova N; Fusté P; Rovirosa A; Gaba L; Buñesch L; Gil-Ibañez B; Pahisa J; Díaz-Feijoo B; Torne A; Ordi J; Del Pino M
    Mod Pathol; 2020 Jan; 33(1):128-137. PubMed ID: 31492932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
    Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
    BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 5. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
    Sznurkowski JJ; Żawrocki A; Biernat W
    BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.
    Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
    Zentralbl Gynakol; 2001 Feb; 123(2):91-101. PubMed ID: 11265139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
    Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
    Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
    Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
    da Mata S; Ferreira J; Nicolás I; Esteves S; Esteves G; Lérias S; Silva F; Saco A; Cochicho D; Cunha M; Del Pino M; Ordi J; Félix A
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study.
    Prigenzi KCK; Heinke T; Salim RC; Focchi GRA
    Acta Cytol; 2018; 62(2):104-114. PubMed ID: 29566392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
    Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
    J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.
    Park JS; Chee YH; Namkoong SE; Han SK; Kim TE; Lee HY; Kim SJ
    Gynecol Oncol; 1994 Jun; 53(3):344-51. PubMed ID: 8206408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implication of human papillomavirus types and species in cervical cancer patients undergoing primary treatment.
    Lau YM; Cheung TH; Yeo W; Mo F; Yu MY; Lee KM; Ho WC; Yeung AC; Law PT; Chan PK
    PLoS One; 2015; 10(4):e0122557. PubMed ID: 25855986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
    Cao L; Sun PL; Yao M; Chen S; Gao H
    Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
    Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
    Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
    Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
    JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human papillomavirus in small cell carcinomas of the anus and rectum.
    Cimino-Mathews A; Sharma R; Illei PB
    Am J Surg Pathol; 2012 Jul; 36(7):1087-92. PubMed ID: 22531171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-DNA, vascular space invasion, and their impact on the clinical outcome in early-stage cervical carcinomas.
    Graflund M; Sorbe B; Sigurdardóttir S; Karlsson M
    Int J Gynecol Cancer; 2004; 14(5):896-902. PubMed ID: 15361201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.
    Ueno S; Sudo T; Oka N; Wakahashi S; Yamaguchi S; Fujiwara K; Mikami Y; Nishimura R
    Int J Gynecol Cancer; 2013 Jul; 23(6):1084-91. PubMed ID: 23792604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.